{"id":"W1971589784","doi":"10.1016/j.bbmt.2009.11.026","title":"Response to Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myelogenous Leukemia Relapsing in Chronic and Advanced Phase Following Allogeneic Hematopoietic Stem Cell Transplantation","year":2009,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Chronic myelogenous leukemia; Dasatinib; Internal medicine; Imatinib; Hematopoietic stem cell transplantation; Tyrosine-kinase inhibitor; Oncology; Transplantation; Nilotinib; Gastroenterology; Leukemia; Odds ratio; Immunology; Cancer; Myeloid leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000651866,0.0001846118,0.0004825479,0.0004183761,0.0002364548,0.0003875543,0.0001372648,0.0003278399,0.000526524],"category_scores_gemma":[0.001855127,0.00009347346,0.0003417823,0.0003638243,0.0002735012,0.0002370489,0.0001631161,0.0003009427,0.0001040857],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002075207,"about_ca_system_score_gemma":0.0001856607,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003272103,"about_ca_topic_score_gemma":0.0005406986,"domain_scores_codex":[0.9996313,0.0001252314,0.00004903949,0.00006182877,0.00006460995,0.00006800244],"domain_scores_gemma":[0.9986338,0.0004964522,0.000539995,0.00004301759,0.00007310941,0.0002136763],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001375503,0.0001173042,0.9844368,0.00003426232,0.000108683,0.0007616141,0.0001368654,0.0001943798,0.002216934,0.00002036924,0.0001246869,0.01047272],"study_design_scores_gemma":[0.0001065193,0.002447794,0.9910058,0.00001829798,0.00008615435,0.004603752,0.0001563794,0.0004873523,0.0005780019,0.00004469599,0.0004568378,0.000008354361],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992884,0.0004665833,0.00004318457,0.00002779712,0.000003408977,0.000005681663,0.00003043416,0.00000190387,0.0001324172],"genre_scores_gemma":[0.9996653,0.0001211655,0.00004030335,0.00003493677,0.00001683214,0.000005582276,0.00008095179,8.107007e-7,0.00003405623],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.000651866,"threshold_uncertainty_score":0.003447413,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006951639614285477,"score_gpt":0.2426961025469065,"score_spread":0.2357444629326211,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}